CORK, Ireland, Feb. 10, 2026 /PRNewswire/ -- ArrayPatch Ltd, a biotech company developing innovative microneedle-based therapeutics, today announced the first close of its €3 million seed funding ...
The phase 1/2 randomized trial compared results from the measles and rubella vaccine delivered by a microarray patch, a small sticking plaster-like device with an array of microscopic projections that ...
Researchers have used 3D-printing technology to improve the viral titer of microneedle array patches, resulting in effective immunogenicity and protection against infection in mice. (Nanowerk News) ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results